Hendrikse, C.S.E.; Theelen, P.M.M.; Verhaegh, W.; Lambrechts, S.; Bekkers, R.L.M.; van de Stolpe, A.; Piek, J.M.J.
Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer. Cancers 2024, 16, 4041.
https://doi.org/10.3390/cancers16234041
AMA Style
Hendrikse CSE, Theelen PMM, Verhaegh W, Lambrechts S, Bekkers RLM, van de Stolpe A, Piek JMJ.
Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer. Cancers. 2024; 16(23):4041.
https://doi.org/10.3390/cancers16234041
Chicago/Turabian Style
Hendrikse, Cynthia S. E., Pauline M. M. Theelen, Wim Verhaegh, Sandrina Lambrechts, Ruud L. M. Bekkers, Anja van de Stolpe, and Jurgen M. J. Piek.
2024. "Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer" Cancers 16, no. 23: 4041.
https://doi.org/10.3390/cancers16234041
APA Style
Hendrikse, C. S. E., Theelen, P. M. M., Verhaegh, W., Lambrechts, S., Bekkers, R. L. M., van de Stolpe, A., & Piek, J. M. J.
(2024). Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer. Cancers, 16(23), 4041.
https://doi.org/10.3390/cancers16234041
